Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Neoplasms
Interventions: DRUG: XL147 (SAR245408)|BIOLOGICAL: trastuzumab|DRUG: paclitaxel
Sponsor: Sanofi